Cancer Trait Revealed to Be a Tragic Flaw Cancer Trait Revealed to Be a Tragic Flaw genprowebdirectory Scroll Up MORE CONTENT We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our privacy policy.Got it! Published at […]
Read More
Decline in Cancer Death Rate Largely Driven by Decreasing Lung Cancer Mortality In 2021, cancer-related death in the United States is projected to continue to decrease, a clinical reality largely driven by declining non-small cell lung cancer (NSCLC) mortality, according to the results of a study published in CA Cancer Journal for Clinicians.1 The American […]
Read More
RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo … TEL AVIV, Israel and RALEIGH, N.C., Jan. 28, 2021 /PRNewswire/ — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced a manufacturing agreement with Cosmo Pharmaceuticals NV (SIX: COPN) (“Cosmo”) to further expand manufacturing capacity for opaganib (Yeliva®, […]
Read More
Liposomal Doxorubicin Market Segmented by Product, Top Manufacturers, Geography Trends … Market Study Report, LLC adds latest research report on ‘ Liposomal Doxorubicin Market’, which delivers a comprehensive study on current industry trends. The outcome also includes revenue forecasts, statistics, market valuations which illustrates its growth trends and competitive landscape as well as the key […]
Read More Cancer patients needing surgery to increase by 5 million globally by 2040: Lancet study The research estimates that there will be a shortfall of about 1,99,000 surgeons and 87,000 anaesthetists to meet the demand in 2040. A modelling and in-depth analysis of the growing demand for cancer surgery, based on data from 183 countries in recent years, predicts […]
Read More
Researchers find drug that is 27.5 times more potent than remdesivir against Covid-19 Researchers in the United States and France have found a drug that has more potential to treat coronavirus than remdesivir. According to a peer-reviewed study published in the Science journal, a drug called plitidepsin is 27.5 times more potent than remdesivir. The […]
Read More
Cancer research goes on despite lockdown The COVID-19 lockdown hasn’t stop the city’s prestigious cancer hospital carrying out pioneering research on cancer treatment. Fudan University Shanghai Cancer Center’s Xuhui branch on Monday launched a clinical trial on a female patient surnamed Zhang to evaluate an experimental treatment for breast cancer. The hospital had planned to carry out the test on January 21, the […]
Read More
Mapping out the treatment of breast cancer-related brain metastases “Am I receiving the right treatment for my cancer?” This question weighs heavily on the minds of all cancer patients. In breast cancer, the increase in categorization of cancer subtypes and rigorous clinical trials have led to clearer guidelines as to which treatments pathways would be […]
Read More
Anti-CDH17/CD3 BiTE May Have Activity in GI Cancers Targeting Cadherin-17 (CDH17) and CD3 with a bispecific T-cell engager (BiTE) may be a novel approach for the treatment of pancreatic and colorectal cancers. Promising preclinical study results were presented at the 2021 Gastrointestinal Cancers Symposium. Aberrant expression of CDH17 is present in 50% to 90% of […]
Read More
Cancer drug is 27.5 times more effective at treating COVID-19 than remdesivir, study suggests Researchers reported Monday in the journal Science that a drug developed to fight multiple myeloma has proved 27.5 times more effective at treating COVID-19 than remdesivir in laboratory studies with infected human lung and kidney cells. The drug, Aplidin or Plitidepsin, […]
Read More